Tissue Engineering Approaches to Treat COPD

Active, not recruitingOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2017

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Lung Cancer
Interventions
PROCEDURE

Patients undergoing standard surgery, excess tissue only will be analysed with patient consent.

Lung samples will be obtained from surplus, healthy margin lung tissue resected from patients with suspected or confirmed lung cancer or from resected tissue from lung volume reduction surgery.

Trial Locations (1)

ST4 6QG

University Hospitals of North Midlands NHS Trust, Stoke-on-Trent

All Listed Sponsors
lead

University Hospitals of North Midlands NHS Trust

OTHER

NCT04878445 - Tissue Engineering Approaches to Treat COPD | Biotech Hunter | Biotech Hunter